American Transplant Congress Philadelphia 2011

5:30 pm- 7:00 pm

• Opening Reception & Exhibits
• Poster Session I

7:00 am - 8:15 am

• Sunrise Symposia
  • HIV & Transplantation: What Have We Learned and Where Are We Going?
  • CD8 Cells: Suppressors and Effectors
  • Controversies in Transplant Pharmacy Practice
  • Deceased Donor Kidney Utilization and the Prospect of Ex-Vivo Repair
  • Infection and Allograft Survival: "Indirect Effects"
  • Preclinical and Clinical Application of Regulatory T Cells in Transplantation Tolerance
  • T Cell Immunity in Clinical Practice
  • Tolerance in Clinical Transplantation through Mixed Chimerism: Update on Trials?
  • The Latest in Extreme Kidney Transplantation
• Early Morning Workshops (Separate Registration Fee)
  • 1. Assessment of Coagulation in End Stage Liver Disease: Pitfalls and Solutions
  • 2. Donation after Circulatory Determination of Death (DCDD) in Children: The Ethics, The Process and the Outcomes
  • 3. Grant Writing Workshop for Basic Science and Clinical Fellows
  • 4. KDIGO Practice Guidelines in Transplant: How and When Should We Use Them , When Should We Not?
  • 5. Surrogate Endpoints in Transplantation
  • 6. The Transplanted Woman: Issues to Consider
  • 7. The Current Status of Islet Transplantation
  • 8. What Do Animal Models Tell Us About Chronic Rejection?

8:30 am - 10:00 am

• Joint Plenary and Awards

10:00 am - 10:30 am

• State-of-the-Art Address

11:00 am - 12:30 pm

• Midday Symposia
  • B Lymphocyte/Plasma Cell Homeostasis in Transplantation
  • Biomarkers as Diagnostic and Prognostic Tools in Organ Transplantation
  • New Insights in Fibrogenesis and Tissue Injury
  • Innovative Strategies to Protect the DCD Liver
  • Update and Future Directions of New Immunosuppressive Therapies in Renal Transplantation
  • Featured Symposium: Infectious Diseases Update for Pediatric Solid Organ Transplant Recipients

2:15 pm - 3:45 pm

• Concurrent Sessions

3:00 pm - 4:30 pm

• Allied Health Symposium

2:15 pm - 5:00 pm

• Transplantation in Depth

4:00 pm- 5:30 pm

• Concurrent Sessions

5:30 pm - 6:30 pm

• Poster Session II

7:00 am - 8:15 am

• Sunrise Symposia
  • Advances in Transplantation for the Diabetic, Uremic Transplant Candidate Through Sequential Kidney and Pancreas or Islet Transplantation
  • B Lymphocytes in Transplant Rejection and Tolerance
  • Beyond the SRTR Expected Outcomes: How Should We Determine the Adequacy of Solid Organ Transplant Programs' Performance?
  • Donor-Derived Infections
  • Kidney Paired Donation: National Experience from US, Korea and Australia
  • Role of Mechanical Circulatory Support in Heart Transplantation
  • The Emerging Field of Vascularized Composite Allotransplantation
  • Hepatitis C Infection after Liver Transplantation
  • Long Term Follow Up of the Living Donor: Ethics vs. Finance
• Early Morning Workshops (Separate Registration Fee)
  • Diving Into the Deep End of the Liver Donor Pool
  • Interpretation of Donor Specific Antibody Testing and Crossmatch Techniques
  • Manuscript Writing Workshop
  • New Onset Diabetes after Transplantation
  • The Older Transplant Recipient
  • Transplant Infectious Diseases: Future Directions
  • What is the Impact of IL-17 on Transplant Outcomes?

8:30 am - 10:00 am

• Joint Plenary and Awards

10:00 am - 10:30 am

• State-of-the-Art Address

11:00 am - 12:30 pm

• Midday Symposia
  • ALDLT: An Update
  • Lymphodepletion and Reconstitution of the T Cell Repertoire
  • microRNAs: New Players in Gene Regulation, Tissue Injury and Rejection
  • Update on "Big Science" in Transplant
  • Viral Hepatitis in Solid Organ Transplantation
  • Featured Symposium: Improving Long-Term Survival in Thoracic Transplantation
  • Transplant Jeopardy

2:15 pm - 3:45 pm

• Concurrent Sessions

3:00 pm - 4:30 pm

• Allied Health Symposium
  • Living with an Organ Transplant in 2011: Management of Cardiovascular and Oncologic Co-Morbidity

2:15 pm - 5:00 pm

• Transplantation in Depth
  • Tolerance is an Active Immunological Process: Part I and Part II

4:00 pm- 5:30 pm

• Concurrent Sessions

5:30 pm - 6:30 pm

• Poster Session III

7:00 am - 8:15 am

• Sunrise Symposia
  • The Critically Ill Lung Transplant Candidate: Clinical Management and Donor Selection
  • Barriers to the Recovery and Placement of High Risk Organs
  • What Every Clinician Should Know About Designing Better Transplant Trials
  • Development of Small Molecules for Therapeutics
  • Immunosuppressive Agents and Infectious Disease
  • Memory T Cell Responses and Induction of Tolerance
  • The Multi-Disciplinary Approach to Hepatocellular Cancer
  • Renal Disease in Liver Transplantation
• Early Morning Workshops (Separate Registration Fee)
  • Grant Writing Workshop for Principal Investigators
  • High Risk Living Donor
  • Immune Privilege in Transplantation
  • Molecular Reading of Transplant Biopsies
  • Role of ECMO in Thoracic Transplantation
  • The Virtual Crossmatch: Understanding its Role in Wait List Management
  • What Are the Barriers to Optimal Utilization and Outcomes for Kidney Transplantation from Small/Young Pediatric Donors?

8:30 am - 10:00 am

• Joint Plenary and Awards

10:00 am - 10:30 am

• Controversies in Transplantation: Geographic Disparities in Liver Transplantation and Novel Approaches for Addressing Them

11:00 am - 12:30 pm

• Presidential Addresses and Awards

2:15 pm - 3:45 pm

• Concurrent Sessions
• FDA Symposium

4:00 pm- 5:30 pm

• Concurrent Sessions

5:30 pm - 6:30 pm

• Poster Session IV

5:30 pm - 8:30 pm

• Career Development Workshop

7:00 am - 8:15 am

• Sunrise Symposia
  • Role of Mechanical Circulatory Support in Heart Transplantation
  • Assessing the Risk for Kidney Allograft Failure
  • Bone Disease in Kidney Transplant Patients: What Diagnostic and Therapeutic Approaches Should We Use?
  • Donor Management: Organ Donation and Critical Care
  • Small Bowel Transplantation: The Basics
  • Stem Cell Mediated Therapy in Transplantation
  • Management of Complications Post Liver Transplantation (ARS)
• Early Morning Workshops (Separate Registration Fee)
  • Challenges in Organ Donor Management
  • Evolving Role of NK Cells in Solid Organ Transplantation
  • Molecular Expression Profiling to Assess Rejection Risk in Heart Transplantation
  • Risks and Solutions in Transplantation and Policy Implications
  • The Current Status of Liver Assist Devices
  • Vascularized Composite Allotransplantation: Development of Donation Best Practices and Establishment of a VCA Program
  • WHCOP Advisory Network
  • Auto Islet Transplantation

8:30 am - 10:00 am

• Joint Plenary and Awards

10:00 am - 10:30 am

• State-of-the-Art Address

10:45 am - 12:15 pm

• Concurrent Sessions

12:15 pm - 1:15 pm

• What's Hot, What's New